HUWE1 Antikörper (C-Term)

Produktnummer ABIN6990752

Produktdetails anti-HUWE1 Antikörper

Target: HUWE1 (HECT, UBA and WWE Domain Containing 1, E3 Ubiquitin Protein Ligase (HUWE1))

Bindungsspezifität: AA 4250-4300, C-Term

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser HUWE1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Aufreinigung: ARF-BP1 Antibody is affinity chromatography purified via peptide column.

Immunogen: ARF-BP1 antibody was raised against a 19 amino acid synthetic peptide from near the carboxy terminus of human ARF-BP1. The immunogen is located within amino acids 4250 - 4300 of ARF-BP1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ARF-BP1 antibody can be used for detection of ARF-BP1 by Western blot at 1 μ,g/mL. Antibody can also be used for immunocytochemistry starting at 5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.

Antibody validated: Western Blot in human samples, Immunocytochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: ARF-BP1 Antibody is supplied in PBS containing 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,4 °C

Informationen zur Lagerung: ARF-BP1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Details zu HUWE1

Target: HUWE1 (HECT, UBA and WWE Domain Containing 1, E3 Ubiquitin Protein Ligase (HUWE1))

Andere Bezeichnung: ARF-BP1 (HUWE1 Produkte)

Synonyme: ARF-BP1 antikoerper, HECTH9 antikoerper, HSPC272 antikoerper, Ib772 antikoerper, LASU1 antikoerper, MULE antikoerper, URE-B1 antikoerper, UREB1 antikoerper, 5430439H10Rik antikoerper, AU041296 antikoerper, Arf-bp1 antikoerper, C430014N20Rik antikoerper, C80292 antikoerper, Gm1718 antikoerper, Mule antikoerper, Ureb1 antikoerper, HUWE1 antikoerper, si:dkey-242a8.2 antikoerper, Huwe1 antikoerper, mule antikoerper, ib772 antikoerper, lasu1 antikoerper, ureb1 antikoerper, hecth9 antikoerper, arf-bp1 antikoerper, hspc272 antikoerper, HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase antikoerper, HECT, UBA and WWE domain containing 1 antikoerper, E3 ubiquitin-protein ligase HUWE1 antikoerper, HUWE1 antikoerper, Huwe1 antikoerper, huwe1 antikoerper, LOC100123214 antikoerper, LOC100380641 antikoerper

Hintergrund: ARF-BP1 Antibody: The ARF tumor suppressor is a critical regulator of p53 stability. In addition to p53, ARF1 binds to other proteins such as MDM2 and ARF-BP1, a large protein containing HECT, UBA and WWE motifs. ARF-BP1 directly binds and ubiquitinates p53, this activity is inhibited by ARF, indicating that ARF-BP1 is a critical mediator of the p53-dependent and p53-independent tumor suppressor functions of ARF. ARF-BP1 can also catalyze the polyubiquitination of Mcl-1, an anti-apoptotic Bcl-2 family member involved in DNA damage-induced apoptosis. Elimination of ARF-BP1 expression by RNA interference stabilized Mcl-1 protein, resulting in an attenuation of apoptosis induced by DNA-damage agents.

Gen-ID: 10075

NCBI Accession: NP_113584

UniProt: Q7Z6Z7